Vital Signs: Trends in Staphylococcus aureus Infections in Veterans Affairs Medical Centers — United States, 2005–2017
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: By 2007, all Department of Veterans Affairs medical centers (VAMCs) had initiated a multifaceted methicillin-resistant Staphylococcus aureus (MRSA) prevention program. MRSA and methicillin-susceptible S. aureus (MSSA) infection rates among VAMC inpatients from 2005 to 2017 were assessed. METHODS: Clinical microbiology data from any patient admitted to an acute-care VAMC in the United States from 2005 through 2017 and trends in hospital-acquired MRSA colonization were examined. RESULTS: S. aureus infections decreased by 43% overall during the study period (p<0.001), driven primarily by decreases in MRSA, which decreased by 55% (p<0.001), whereas MSSA decreased by 12% (p = 0.003). Hospital-onset MRSA and MSSA infections decreased by 66% (p<0.001) and 19% (p = 0.02), respectively. Community-onset MRSA infections decreased by 41% (p<0.001), whereas MSSA infections showed no significant decline. Acquisition of MRSA colonization decreased 78% during 2008-2017 (17% annually, p<0.001). MRSA infection rates declined more sharply among patients who had negative admission surveillance MRSA screening tests (annual 9.7% decline) compared with those among patients with positive admission MRSA screening tests (4.2%) (p<0.05). CONCLUSIONS AND IMPLICATIONS FOR PUBLIC HEALTH PRACTICE: Significant reductions in S. aureus infection following the VAMC intervention were led primarily by decreases in MRSA. Moreover, MRSA infection declines were much larger among patients not carrying MRSA at the time of admission than among those who were. Taken together, these results suggest that decreased MRSA transmission played a substantial role in reducing overall S. aureus infections at VAMCs. Recent calls to withdraw infection control interventions designed to prevent MRSA transmission might be premature and inadvisable, at least until more is known about effective control of bacterial pathogen transmission in health care settings. Effective S. aureus prevention strategies require a multifaceted approach that includes adherence to current CDC recommendations for preventing not only device- and procedure-associated infections, but also transmission of health care-prevalent strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“and may be decreasing according to some reports [134, 135]”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [135]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These include a range of adverse events such as allergic or hypersensitivity reactions, kidney injury, thrombocytopenia, Clostridioides difficile infection, and antimicrobial resistance (101-106).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [101]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kourtis, A. P., Hatfield, K., Baggs, J., Mu, Y., See, I., Epson, E., Nadle, J., Kainer, M. A., Dumyati, G., Petit, S., et al. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6809e1 · Cited by 701
Self-citationVeterans Affairs Initiative to Prevent Methicillin-Resistant Staphylococcus aureus Infections
Jain, R., Kralovic, S. M., Evans, M. E., Ambrose, M., Simbartl, L. A., Obrosky, D. S., Render, M. L., Freyberg, R. W., Jernigan, J. A., Muder, R. R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007474 · Cited by 496 · cited 1×
“, wearing a gown and gloves for all interactions involving contact with the patient or the patient’s environment) for patients found to be carriers (1).”
BackgroundSelf-citationThe epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions
Lipsitch, M., Bergstrom, C. T., & Levin, B. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1938 · Cited by 424 · cited 1×
“Models predict that a decrease in overall transmission of bacterial pathogens in health care settings will result in disproportionately greater impact on strains having characteristics that provide a selective advantage for health care transmission, such as resistance to multiple antibiotics, including MRSA (8,9).”
BackgroundContact Precautions for Endemic MRSA and VRE: Time to Retire Legal Mandates
Morgan, D. J., Wenzel, R. P., & Bearman, G. M. (2017) · JAMA · doi:10.1001/jama.2017.7419 · Cited by 70 · cited 2×
“These data suggest that recent calls to withdraw infection control interventions (5) designed to prevent MRSA transmission, such as use of contact precautions, might be premature and inadvisable, at least until more is known about effective control of bacterial pathogen transmission in health care settings.”
BackgroundJones, M., DuVall, S. L., Spuhl, J., Samore, M. H., Nielson, C., & Rubin, M. A. (2012) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-12-34 · Cited by 60 · cited 1×
“Clinical diagnostic culture and MRSA surveillance test results were extracted from electronic health records as described elsewhere (3).”
MethodSelf-citationSee, I., Mu, Y., Albrecht, V. S., Karlsson, M., Dumyati, G. K., Hardy, D. J., Koeck, M., Lynfield, R., Nadle, J., Ray, S. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz158 · Cited by 48
Goto, M., O'Shea, A. M. J., Livorsi, D. J., McDanel, J. S., Jones, M. M., Richardson, K. K., Beck, B. F., Alexander, B., Evans, M. E., Roselle, G. A., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw423 · Cited by 43 · cited 1×
“A sustained decline in gramnegative rod bloodstream infections in the VA system after implementation of the MRSA prevention program was also observed (10).”
BackgroundSelf-citationWhy sensitive bacteria are resistant to hospital infection control
van Kleef, E., Luangasanatip, N., Bonten, M. J. M., & Cooper, B. S. (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.11033.1 · Cited by 36 · cited 1×
“Models predict that a decrease in overall transmission of bacterial pathogens in health care settings will result in disproportionately greater impact on strains having characteristics that provide a selective advantage for health care transmission, such as resistance to multiple antibiotics, including MRSA (8,9).”
BackgroundJones, M., Nielson, C., Gupta, K., Khader, K., & Evans, M. E. (2014) · American Journal of Infection Control · doi:10.1016/j.ajic.2014.09.016 · Cited by 14 · cited 1×
“However, it is likely that contact precautions for MRSA-colonized patients contributed to this trend: another VA study showed that 31% of patients with multidrug-resistant gram-negative bacteria would have been under contact precautions because of a positive MRSA screen (11).”
ResultSelf-citationKanwar, A., Cadnum, J. L., Jencson, A. L., & Donskey, C. J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00609-18 · Cited by 11 · cited 1×
“There is evidence that fluoroquinolone use is associated with increased MRSA colonization (12), and the reduction in fluoroquinolone use could contribute to selective reduction in MRSA because it is more commonly fluoroquinolone-resistant than is MSSA.”
Background
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Kourtis, A. P., Hatfield, K., Baggs, J., Mu, Y., See, I., Epson, E., Nadle, J., Kainer, M. A., Dumyati, G., Petit, S., et al. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6809e1 · Cited by 701
“Meanwhile, evidence from the National Veterans Affairs system suggests that decreasing hospital transmission of MRSA likely also contributed to the observed reductions (19,20).”
BackgroundSelf-citationKern, W. V., & Rieg, S. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.10.031 · Cited by 355
Key takeaways from the U.S. CDC’s 2019 antibiotic resistance threats report for frontline providers
Kadri, S. S. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004371 · Cited by 292
Popovich, K. J., Aureden, K., Ham, D. C., Harris, A. D., Hessels, A., Huang, S. S., Maragakis, L. L., Milstone, A. M., Moody, J. A., Yokoe, D. S., et al. (2023) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2023.102 · Cited by 175
Jones, B. E., Ying, J., Stevens, V., Haroldsen, C., He, T., Nevers, M., Christensen, M. A., Nelson, R. E., Stoddard, G. J., Sauer, B. C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.7495 · Cited by 122
Self-citationControl of MSSA and MRSA in the United States: protocols, policies, risk adjustment and excuses
Kavanagh, K. T. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0550-2 · Cited by 96
Improving the Use of Personal Protective Equipment: Applying Lessons Learned
Reddy, S. C., Valderrama, A. L., & Kuhar, D. T. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz619 · Cited by 77
Chow, H. Y., Po, K. H. L., Gao, P., Blasco, P., Wang, X., Li, C., Ye, L., Jin, K., Chen, K., Chan, E. W., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01957 · Cited by 53
Schweizer, M. L., Richardson, K. K., Vaughan‐Sarrazin, M., Goto, M., Livorsi, D. J., Nair, R., ALEXANDER, B. K., Beck, B. F., Jones, M. P., Puig‐Asensio, M., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1572 · Cited by 50
Self-citationGarza‐González, E., Franco‐Cendejas, R., Morfín‐Otero, R., Echániz-Avilés, G., Rojas‐Larios, F., Bocanegra‐Ibarias, P., Flores-Treviño, S., Ponce‐de‐León, A., Rodríguez-Noriega, E., Alavez-Ramírez, N., et al. (2020) · Microbial Drug Resistance · doi:10.1089/mdr.2019.0354 · Cited by 41
Punjabi, C. D., Madaline, T. F., Gendlina, I., Chen, V., Nori, P., & Pirofski, L. (2020) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2020.440 · Cited by 37
Overuse of Broad-Spectrum Antibiotics for Pneumonia
Klompas, M. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.7251 · Cited by 34
Khader, K., Thomas, A., Stevens, V. W., Visnovsky, L. D., Nevers, M. R., Toth, D. J. A., Keegan, L. T., Jones, M., Rubin, M. A., & Samore, M. H. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.0971 · Cited by 30
Self-citationMoussally, M., Zahreddine, N. K., Kazma, J. M., Ahmadieh, R., Kan, S. S., & Kanafani, Z. A. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.11.006 · Cited by 28
Emergency medicine updates: Management of sepsis and septic shock
Long, B., & Gottlieb, M. A. (2025) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2025.01.054 · Cited by 34
Evans, M. E., Simbartl, L. A., McCauley, B. P., Flarida, L., Jones, M., Harris, A. D., Perencevich, E. N., Rubin, M. A., Hicks, N. R., Kralovic, S. M., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad388 · Cited by 25
Self-citationChen, Y., Liu, L., Wang, X., Liao, Z., Wang, R., Xiong, Y., Cheng, J., Jiang, G., Wang, J., & Liao, X. (2022) · Dalton Transactions · doi:10.1039/d2dt01531e · Cited by 24
Pham, T. M., Zhang, Y., Nevers, M. R., Li, H., Khader, K., Grad, Y. H., Lipsitch, M., & Samore, M. H. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00416-x · Cited by 25
Self-citationAntimicrobial Resistance Genes Analysis of Publicly Available Staphylococcus aureus Genomes
Pennone, V., Maradona, M. P., Álvarez‐Ordóñez, A., & Cobo-Díaz, J. F. (2022) · Antibiotics · doi:10.3390/antibiotics11111632 · Cited by 28
“Another study, analysing MRSA infections in patients of the Veterans Affairs medical centres in the USA from 2005 to 2017, also showed a decreasing trend of MRSA infections [48].”
ResultLee, A. S., Huttner, B. D., Catho, G., & Harbarth, S. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.07.001 · Cited by 26
Wong, S., Chen, J. H., Yuen, L. L.-H., Chan, V. W.-M., AuYeung, C. H.-Y., Leung, S. S.-M., So, S.-Y., Chan, B. W.-K., Li, X., Leung, J., et al. (2022) · Journal of Hospital Infection · doi:10.1016/j.jhin.2022.02.012 · Cited by 20
Epidemiology and Mortality of Invasive Staphylococcus aureus Infections in Hospitalized Infants
Jennings, M. R., Elhaissouni, N., Colantuoni, E., Prochaska, E. C., Johnson, J., Xiao, S., Clark, R. H., Greenberg, R. G., Benjamin, D. K., & Milstone, A. M. (2025) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2025.0429 · Cited by 18
Pearson, T., Barger, S. D., Lininger, M. R., Wayment, H. A., Hepp, C. M., Villa, F., Tucker-Morgan, K., Kyman, S., Cabrera, M., Hurtado, K. A., et al. (2019) · JMIR Research Protocols · doi:10.2196/14853 · Cited by 9
“Invasive MRSA infections in health care settings have been declining, but community MSSA infections are increasing slightly [3,5].”
Ruan, Z., Cui, J., He, Z., Guo, Y., Jia, X., & Huang, X. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s255296 · Cited by 9
Ham, D. C., See, I., Novosad, S., Crist, M. B., Mahon, G., Fike, L. V., Spicer, K. B., Talley, P. P., Flinchum, A. H., Kainer, M. A., et al. (2020) · Journal of Hospital Infection · doi:10.1016/j.jhin.2020.04.007 · Cited by 9
Klein, E. Y., Zhu, X., Petersen, M. R., Patel, E. U., Cosgrove, S. E., & Tobian, A. A. R. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab585 · Cited by 8
Analyzing the Cost of Hospital Contact Isolation Practices
Saber, D. A., Norris, A. E., Reinking, J., Trompeter, G., & Sanford, D. (2022) · JONA The Journal of Nursing Administration · doi:10.1097/nna.0000000000001160 · Cited by 7
Wang, G., Wen, J., Tian, Z., Zhou, H., Peng, X., Zhang, P., & Li, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-89654-1 · Cited by 6
Improving Vancomycin Stewardship in Critically Ill Children
Chiotos, K., Fitzgerald, J. C., Hayes, M., Dashefsky, H., Metjian, T. A., Woods-Hill, C. Z., Biedron, L., Stinson, H. R., Ku, B. C., Tighe, S., et al. (2022) · PEDIATRICS · doi:10.1542/peds.2021-052165 · Cited by 9
Antibiotic resistance incidence or proportions: where does the greatest burden lie?
Walker, M. K., & Kadri, S. S. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00485-7 · Cited by 6
Ahmed, O. B., Bahwerth, F. S., Alsafi, R., Elsebaei, E. A., Ebid, G., Theyab, A., & Assaggaf, H. M. (2024) · Cureus · doi:10.7759/cureus.54809 · Cited by 5
“Recently (before COVID-19), it has been reported that there has been a decrease in the rate of MRSA infections in some countries [21,25].”
BackgroundInfluentialFan, Y., Sekar, A., McCanne, M., Yuh, J., Kannambadi, D. D., Lekkala, S., Muratoglu, O. K., & Oral, E. (2025) · Scientific Reports · doi:10.1038/s41598-025-95004-y · Cited by 4
“We selected the strains in this study based on the prevalence of MSSA and MRSA in medical-device infections 33 .”
Cranmer, K. D., Pant, M. D., Quesnel, S., & Sharp, J. A. (2023) · Pathogens · doi:10.3390/pathogens13010025 · Cited by 6
“In recent years, the rate of infection by methicillin resistant S. aureus (MRSA) has decreased, stabilizing increases seen in the late 1990s to early 2000s [4,10], with a shift in concern to vancomycin and clindamycin resistance currently [11–15].”
Staphylococcus aureus transcriptomics and single-cell sequencing approaches
Małachowa, N., & DeLeo, F. R. (2025) · Infection and Immunity · doi:10.1128/iai.00411-25 · Cited by 3
“The significant decline in U.S. MRSA infections since 2005, especially among hospital-acquired infections (HAIs) (21, 22), may have been attributed to improved strategies to prevent MRSA transmission (23), standardized treatment guidelines (24), as well as a decrease in infections caused by USA100…”
Kobayashi, T., Ai, C., Jung, M., Salinas, J. L., & Yu, K. C. (2024) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2024.402 · Cited by 4
“14 Moreover, a population-based study in Minnesota examining the incidence of monomicrobial staph bacteremia between 2006 and 2020 demonstrated that there was no apparent temporal trend over 15 years with a stable incidence.”
BackgroundLeal, J. R., Zhang, Z., Armstrong, L., Pitchko, J., Lee, B., Versluys, K., Chow, B., Ellison, J., Pfister, T. R., Woolsey, S., et al. (2026) · American Journal of Infection Control · doi:10.1016/j.ajic.2026.01.007 · Cited by 2
Childhood Antimicrobial Resistance With Global Forecasts
Hu, Y. J., Qiu, H., Harwell, J. I., & Bryant, P. A. (2026) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2026.2808 · Cited by 3
Alabdullatif, M. (2024) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.18.4.12 · Cited by 2
Marked Reduction of Vancomycin Utilization in a Veterans Hospital
Froehlich, M., Ford, F. M., Belal, M., Creed, M., Lobo, Z., & Psevdos, G. (2020) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000826 · Cited by 2
O’Hara, L. M., Pineles, L. L., Newman, M., Bahr-Robertson, M. K., Baracco, G. J., Goetz, M. B., Ikuta, K. S., Crnich, C. J., Bradley, S., Linder, K. A., et al. (2025) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2025.10253 · Cited by 2
Self-citationKavanagh, K. T., Maiwald, M., & Cormier, L. E. (2024) · Medicine · doi:10.1097/md.0000000000039200 · Cited by 1
“In reporting the VHA data, Jones et al [33] stated that the implementation of multi-faceted control interventions: “...included admission screening for nasal MRSA carriage and use of contact precautions for MRSA-colonized patients, VAMCs across the United States experienced a sharp decline in S.…”
Niforatos, J. D., Hinson, J. S., Rothman, R. E., Cosgrove, S. E., Dzintars, K., & Klein, E. Y. (2025) · Journal of the American College of Emergency Physicians Open · doi:10.1016/j.acepjo.2024.100021 · Cited by 3
Martínez-Ayala, P., Arcos-Jiménez, J. C. D., Gómez-Quiroz, A., Avila-Cardenas, B. B., Damian-Negrete, R., Yáñez, A. M. L., García-Miranda, L., Álvarez-Alba, C. R., & Briseño-Ramírez, J. (2025) · Research Square · doi:10.21203/rs.3.rs-7228547/v1
The Evolving Etiology of Hospital-Acquired and Ventilator-Associated Pneumonia
Besien, R. F. V., & Guillamet, C. V. (2026) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2025.12.013
Beyond Methicillin-Resistant Staphylococcus aureus
Bosetti, D., Lee, A., Catho, G., & Harbarth, S. (2026) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2026.01.011
Polysubstance use and risk of infectious diseases: Evidence from a national cohort, 2018–2023
Khan, S. I., Wen, S., Fisher, M., Rudisill, T. M., & Bhandari, R. (2026) · Annals of Epidemiology · doi:10.1016/j.annepidem.2026.110266
Linam, W. M., Gonzalez, M. D., Black, G., Keenum, P., Spafford, P. S., & Nguyen, S. T. (2026) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2026.10792
Nakaminami, H. (2026) · Antibiotics · doi:10.3390/antibiotics15100971
“Notably, the implementation of a nationwide MRSA prevention initiative in the U.S. Department of Veterans Affairs healthcare system was associated with significant reductions in hospital-onset MRSA infections and MRSA acquisition [47,48].”
Metadata
- Authors
- Jones, M., Jernigan, J. A., Evans, M. E., Roselle, G. A., Hatfield, K. M., & Samore, M. H.
- Affiliations
- University of Utah (US)
- Corresponding author
- Jones, Makoto
- ORCID
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2019-03-08
- Volume
- 68
- Issue
- 9
- Pages
- 220-224
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- PMC
- PMC6421970
- OpenAlex
- W2918922525
- Cited by
- 50
- References
- 11
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 6 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 11 · 2019: 5
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- Staphylococcus aureus infection, methicillin-resistant Staphylococcus aureus, methicillin-susceptible Staphylococcus aureus, MRSA prevention, nosocomial infections, MRSA colonization, infection control interventions, veterans, veterans' hospitals, infection trends, MRSA transmission, antimicrobial resistance
- MeSH terms
- Cross Infection, Female, Hospitals, Veterans, Humans, Male, Methicillin, Staphylococcal Infections, Staphylococcus aureus, United States, Infection Control, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.